NCT05299125
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05299125
Title Amivantamab, Lazertinib, and Pemetrexed for First-line Treatment of Recurrent/Metastatic Non-small Cell Lung Cancers With Epidermal Growth Factor Receptor Mutations (AMIGO-1)
Acronym AMIGO-1
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Latin American Cooperative Oncology Group
Indications
Therapies
Age Groups: senior | adult
Covered Countries BRA

Facility Status City State Zip Country Details
Pronutrir - Oncologia e Nutrição Fortaleza Ceará 60810-180 Brazil Details
Hospital Evangélico de Cachoeiro de Itapemirim Cachoeiro de Itapemirim Espírito Santo 29308-065 Brazil Details
Hospital Erasto Gaertner Curitiba Paraná 81520-060 Brazil Details
INCA - Instituto Nacional de Câncer Rio de Janeiro Rio de Janeiro 20230-130 Brazil Details
Centro de Tratamento de Tumores Botafogo (Oncoclínicas) Rio de Janeiro Rio de Janeiro 22250-905 Brazil Details
Liga Norte Riograndense Contra o Câncer Natal Rio Grande do Norte 59062-000 Brazil Details
Irmandade da Santa Casa de Misericórdia de Porto Alegre Porto Alegre Rio Grande do Sul 90050-170 Brazil Details
Centro de Pesquisa em Oncologia do Hospital São Lucas da PUCRS Porto Alegre Rio Grande do Sul 91751-443 Brazil Details
Hospital de Amor de Barretos Barretos São Paulo 14784400 Brazil Details
Hospital de Base de São José do Rio Preto São José do Rio Preto São Paulo 15090-000 Brazil Details
ICESP - Instituto do Câncer do Estado de São Paulo São Paulo São Paulo 01246-000 Brazil Details
BP - A Beneficência Portuguesa de São Paulo São Paulo São Paulo 01323-030 Brazil Details
São Camilo Oncologia São Paulo São Paulo 04014-002 Brazil Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field